News Release

Online tools can improve autism diagnosis

Peer-Reviewed Publication

Swansea University

Online tools can help improve autism diagnosis

image: Online tools and assessments can help speed up diagnosis of autism spectrum disorder (ASD), the first comprehensive survey of research in the field has concluded. The research was conducted by a team led by experts from Swansea University Medical School. view more 

Credit: Swansea University

Online tools and assessments can help speed up diagnosis of autism spectrum disorder (ASD), the first comprehensive survey of research in the field has concluded.

The survey showed that using internet-based tools in healthcare - a field known as telehealth - has potential to improve services in autism care, when used alongside existing methods.

The research, published today in PLOS ONE, was conducted by a team led by experts from Swansea University Medical School. The results are timely as the Covid-19 pandemic is prompting fresh thinking about providing services online.

Currently it can sometimes take several years after someone first seeks help before ASD diagnosis is confirmed. This can be due to a shortage of expertise, to several appointments being necessary, and the fact that the process can be very stressful for individuals who might later be diagnosed with ASD. As these are specialist services, they can also require lots of travelling for families and experts alike.

Delays in diagnosis can lead to poor outcomes for both the families and individuals.

Telehealth is already used successfully in areas such as radiology, cardiology, mental health, and for monitoring patients with diabetes and hypertension. However, the new study is the first to review the existing literature on the use of telehealth to support ASD diagnostic assessment.

The research team surveyed twenty years' worth of research in fields related to autism and telehealth, narrowing down an initial sample of 3700 articles to a set of ten for close study.

They examined which telehealth approaches have been used in the diagnosis and assessment of ASD in children and adults and how they compare with face-to-face methods.

The review revealed two main approaches to using telehealth:

1 Real-Time method - for example, videoconferencing, which enables a range of health professionals in different areas to meet in real time with the family to assess the child or adult, reducing the need for travel or multiple appointments

2 Store-and-Forward method - this involves providing a way for parents/carers to upload videos of a child's behaviour to a web portal, enabling clinicians to see a child in their everyday surroundings, to better inform the assessment.

The team found evidence that these two approaches: * are acceptable to both families and clinicians; * have good diagnostic accuracy; * enable families from a wider area to access professionals; * reduce costs for accessing care; * enable the natural behaviours in the home setting to be observed; * may enable both parents in divorced families to contribute to the diagnostic process.

Professor Sinead Brophy of Swansea University Medical School said:

"Telehealth can potentially improve the efficiency of the diagnosis process for ASD.

The evidence reviewed in our study shows that it can reduce delays and improve outcomes, when used in conjunction with existing methods. It could be of particular benefit to those with clear autism traits and adults with ASD.

Telehealth methods allow for collaboration and the sharing of experiences between the family, education and ASD experts. They can be just as good as face-to-face methods in terms of satisfaction for the patient, family and clinician."

Manahil Alfuraydan of Swansea University Medical School, primary author of the research, said:

"They reduce the time to diagnosis, particularly for those with more severe autism where there is good agreement in terms of the diagnosis compared to the face to face methods.

Our study highlights the potential of telehealth. Larger randomised controlled trials of this technology in relation to ASD are warranted."


Notes to editors:

The research was published in PLOS ONE

The research team are: Manahil Alfuraydan 1,2*, Jodie Croxall 1, Lisa Hurt 3, Mike Kerr 4, Sinead Brophy 5

1School of Medicine, Swansea University, Swansea, UK
2 College of Applied Medical Sciences, King Faisal University, Saudi Arabia
3 Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK
4 Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK
5 National Centre for Population Health and Wellbeing, School of Medicine, Swansea University, UK

Swansea University is a world-class, research-led, dual campus university offering a first-class student experience and has one of the best employability rates of graduates in the UK. The University has the highest possible rating for teaching - the Gold rating in the Teaching Excellence Framework (TEF) in 2018 and was commended for its high proportions of students achieving consistently outstanding outcomes.

Swansea climbed 14 places to 31st in the Guardian University Guide 2019, making us Wales' top ranked university, with one of the best success rates of graduates gaining employment in the UK and the same overall satisfaction level as the Number 1 ranked university.

The 2014 Research Excellence Framework (REF) 2014 results saw Swansea make the 'biggest leap among research-intensive institutions' in the UK (Times Higher Education, December 2014) and achieved its ambition to be a top 30 research University, soaring up the league table to 26th in the UK.

The University is in the top 300 best universities in the world, ranked in the 251-300 group in The Times Higher Education World University rankings 2018. Swansea University now has 23 main partners, awarding joint degrees and post-graduate qualifications.

The University was established in 1920 and was the first campus university in the UK. It currently offers around 350 undergraduate courses and 350 postgraduate courses to circa 20,000 undergraduate and postgraduate students. The University has ambitious expansion plans as it moves towards its centenary in 2020 and aims to continue to extend its global reach and realise its domestic and international potential.

Swansea University is a registered charity. No.1138342. Visit

For more information:

Kevin Sullivan, Swansea University Public Relations Office

Follow us on Twitter:

Find us on Facebook:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.